Healthcare 2019: What The Future Holds For The Pharma Industry
Pharma Bio World|February 2019

Medicines continue to form the mainstay of treatment methods for most medical conditions known today, despite some speculations that chemicals in the human body may be self-regulated via nanobots in the future.

Healthcare 2019: What The Future Holds For The Pharma Industry

But that future is still 50 years away. At present, healthcare is still learning to cope with the possibilities of precision medicine and artificial intelligence.

The domestic pharmaceuticals market is said to be the world’s third largest in terms of volume and thirteenth largest by value. Implying that one out of every three tablets available anywhere in the world has been produced by an Indian company. The sector was valued at USD 33 billion in 2017; and by September 2018, the market had grown by 9.7% to tally almost USD 18 billion. The US makes up for 40% of all generic medicine demand from India, while its pharma workforce boasts of great representation in new drug applications and drug master files applications in the country. Healthcare has seen a clear shift toward patient centrality and quality enhancement while pharmaceuticals are moving towards niche products. There are several new areas, which modern pharma employees need to have knowledge of and train themselves to remain relevant and have a sustainable role in tomorrow’s industry.

Biosimilars and rare diseases

This story is from the February 2019 edition of Pharma Bio World.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the February 2019 edition of Pharma Bio World.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM PHARMA BIO WORLDView All
More Efficiency, More Communication
Pharma Bio World

More Efficiency, More Communication

B&R has published a new major release of its APROL process control system. APROL R 4.2 contains numerous new software functions, including improved cloud communication via OPC UA and MQTT. It also offers a modern new “Dark style” interface design option.

time-read
1 min  |
June 2018
Phytopharmaceuticals & Their Role In Human Health
Pharma Bio World

Phytopharmaceuticals & Their Role In Human Health

Nutraceuticals and functional foods on an average are globally becoming giant players in health sector. In a survey, it was reported that in year 2010 alone, there was a huge market growth of nutraceuticals and food supplements. Phytopharmaceuticals, nutraceuticals and functional foods have the potential to substantially reduce the expensive, high-tech, disease treatment approaches particularly common in developed countries. Charu Gupta and Dhan Prakash from Amity Institute for Herbal Research & Studies explores the world of Phytopharmaceuticals and nutraceuticals in this article.

time-read
7 mins  |
September 2018
Bosch Packaging Technology Showcases Laboratory Competence In R&D And Industry 4.0
Pharma Bio World

Bosch Packaging Technology Showcases Laboratory Competence In R&D And Industry 4.0

One of the leading suppliers of process and packaging technology, Bosch Packaging Technologys new laboratory device Xelum R&D for continuous manufacturing is an example of how the Bosch Pharma Service and Industry 4.0 solutions support pharmaceutical manufacturers in increasing transparency and efficiency of their laboratory processes.

time-read
1 min  |
September 2018
ECOFLUX* Corrugated Tube Heat Exchanger
Pharma Bio World

ECOFLUX* Corrugated Tube Heat Exchanger

HRS Process Systems Ltd, India, is part of UK-based HRS group of companies, a leading heat transfer technology provider.

time-read
1 min  |
September 2018
WACKER Invests In Jena Biotech Site
Pharma Bio World

WACKER Invests In Jena Biotech Site

The Munich-based chemical group WACKER has enhanced its production facilities for biopharmaceuticals also known as biologics with new equipment.

time-read
1 min  |
September 2018
Unsolved Chronic Wounds Increasing Rapidly In India…
Pharma Bio World

Unsolved Chronic Wounds Increasing Rapidly In India…

+dalethyne, a path breaking molecule, only one of its kind in the world, invented after 18 years of untiring research since 2000 by K.S. Dharshan, the Founder and Chairman of Indonesia based Dermozone , is all set to revolutionize the wound care market in India. +dalethyne would be the key ingredient of the new Dermozone range of wound care products soon to be launched in India. Mr. K.S. Dharshan, CEO – Dermozone gives us more details in this brief interview with PharmaBio World.

time-read
2 mins  |
November 2018
Making Water Safe Through Quick Detection Of Legionella
Pharma Bio World

Making Water Safe Through Quick Detection Of Legionella

Legionellosis is a collective term for diseases caused by legionella bacteria including the most serious Legionnaires’ disease, as well as the similar but less serious conditions of Pontiac fever and Lochgoilhead fever.

time-read
2 mins  |
February 2019
Solid Dosage: Technologies To Tablet Effervescent Products
Pharma Bio World

Solid Dosage: Technologies To Tablet Effervescent Products

Tableting effervescent products is a complex process.

time-read
4 mins  |
February 2019
Unmatched Efficiency With High-speed Diverters
Pharma Bio World

Unmatched Efficiency With High-speed Diverters

B&R presents flexible transport system at Hannover MesseB&R’s new flexible transport system is designed to deliver ultimate production effectiveness – from mass pro-duction down to batches of one. Playing a pivotal role in making this possible are the system’s purely elec-tromagnetic diverters, which are able to divide and merge product flows at full production speed. B&R will be presenting its transport system from April 23-27 at the Hannover Messe in Hall 9, Booth D26.

time-read
1 min  |
March 2018
Digitalization Is Not An Option, But A Must
Pharma Bio World

Digitalization Is Not An Option, But A Must

B&R India explores IIoT topics at 4th annual Innovation Day.

time-read
2 mins  |
March 2018